Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths : a before (2006-10) versus after (2011-13) comparison

Bird, Sheila M. and McAuley, Andrew and Perry, Samantha and Hunter, Carole (2016) Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths : a before (2006-10) versus after (2011-13) comparison. Addiction. ISSN 0965-2140

[img]
Preview
Text (Bird-etal-Addiction2016-effectiveness-of-Scotland's-National-Naloxone-Programme-for-reducing-opioid-related-deaths)
Bird_etal_Addiction2016_effectiveness_of_Scotland_s_National_Naloxone_Programme_for_reducing_opioid_related_deaths.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (231kB)| Preview

    Abstract

    Aims: To assess the effectiveness for Scotland's National Naloxone Programme (NNP) bycomparison between 2006-10 (before) and 2011-13 (after NNP started in January2011) and to assess cost-effectiveness. Design: This was a pre-post evaluation of a national policy. Cost-effectiveness was assessedby prescription costs against life-years gained per opioid-related death (ORD) averted. Setting: Scotland, in community settings and all prisons. Intervention: Brief training and standardized naloxone supply became available to individuals at risk of opioid overdose. Measurements: ORDs as identified by National Records of Scotland. Look-back determined the proportion of ORDs who, in the 4 weeks before ORD, had been (i) released from prison (primary outcome) and (ii) released from prison or discharged from hospital (secondary). We report 95% confidence intervals for effectiveness inreducing the primary (and secondary) outcome in 2011-13 versus 2006-10. Prescription costs were assessed against 1 or 10 life-years gained per averted ORD. Findings: In 2006-10, 9.8% of ORDs (193 of 1970) were in people released from prison within 4 weeks of death, whereas only 6.3% of ORDs in 2011-13 followed prison release(76 of 1212, P < 0.001; this represented a difference of 3.5% [95% confidence interval (CI) = 1.6-5.4%)]. This reduction in the proportion of prison release ORDs translates into 42 fewer prison release ORDs (95% CI =19-65) during 2011-13, when 12 000 naloxone kits were issued at current prescription cost of £225 000. Scotland's secondary outcome reduced from 19.0 to 14.9%, a difference of 4.1% (95% CI = 1.4-6.7%). Conclusions: Scotland's National Naloxone Programme, which started in 2011, was associated with a 36% reduction in the proportion of opioid-related deaths that occurred in the 4 weeks following release from prison.